---
figid: PMC10455455__hs9-7-e943-g003
pmcid: PMC10455455
image_filename: hs9-7-e943-g003.jpg
figure_link: /pmc/articles/PMC10455455/figure/F2/
number: Figure 2
figure_title: ''
caption: Significant mutations and NGS impact by disease subtype. (A) Significant
  mutations by disease subtype (n = 3945). Significant mutations are indicated in
  blue, absence thereof in orange. (B) Impact of the NGS test on the patient pathway
  by disease subtype (n = 3961). n = total number of reported index prescriptions;
  NGS = next-generation sequencing.
article_title: 'Targeted High-throughput Sequencing for Hematological Malignancies:
  A GBMHM Survey of Practice and Cost Evaluation in France.'
citation: Meryl Darlington, et al. Hemasphere. 2023 Sep;7(9):e943.
year: '2023'

doi: 10.1097/HS9.0000000000000943
journal_title: HemaSphere
journal_nlm_ta: Hemasphere
publisher_name: Lippincott Williams & Wilkins

keywords:
---
